Jayakrishnan Krishnakurup, MD

05/20/2010
Jayakrishnan Krishnakurup, MD; David Witt, MD; Vivian Argento, MD
Myocardial toxicity of 5-FU should be considered in any patient with chest pain who had recent exposure to this chemotherapeutic agent.
05/20/2010
05/20/2010
Jayakrishnan Krishnakurup, MD; David Witt, MD; Vivian Argento, MD
Myocardial toxicity of 5-FU should be considered in any patient with chest pain who had recent exposure to this chemotherapeutic agent.
05/20/2010
05/20/2010
Jayakrishnan Krishnakurup, MD; David Witt, MD; Vivian Argento, MD
Myocardial toxicity of 5-FU should be considered in any patient with chest pain who had recent exposure to this chemotherapeutic agent.
05/20/2010
Case Report
Case Report
10/13/2011
Vivian Argento, MD; Mithil Choksey, MD; Beata Skudlarska, MD; Jayakrishnan Krishnakurup, MD; David Witt, MD
It is prudent to rule out TTP in all cases of thrombocytopenia associated with clopidogrel.
10/13/2011
Case Report
Case Report
10/13/2011
Vivian Argento, MD; Mithil Choksey, MD; Beata Skudlarska, MD; Jayakrishnan Krishnakurup, MD; David Witt, MD
It is prudent to rule out TTP in all cases of thrombocytopenia associated with clopidogrel.
10/13/2011
Case Report
Case Report
10/13/2011
Vivian Argento, MD; Mithil Choksey, MD; Beata Skudlarska, MD; Jayakrishnan Krishnakurup, MD; David Witt, MD
It is prudent to rule out TTP in all cases of thrombocytopenia associated with clopidogrel.
10/13/2011
Case Report
Case Report
10/13/2011
Vivian Argento, MD; Mithil Choksey, MD; Beata Skudlarska, MD; Jayakrishnan Krishnakurup, MD; David Witt, MD
It is prudent to rule out TTP in all cases of thrombocytopenia associated with clopidogrel.
10/13/2011
Case Report
Case Report
10/13/2011
Vivian Argento, MD; Mithil Choksey, MD; Beata Skudlarska, MD; Jayakrishnan Krishnakurup, MD; David Witt, MD
It is prudent to rule out TTP in all cases of thrombocytopenia associated with clopidogrel.
10/13/2011